MyFinsight
Home
About
Contact
tern: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, TERN has $301,651K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
301,651
320,415
Total stockholders' equity
284,066
305,229
Total liabilities and stockholders' equity
301,651
320,415
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$4,660K
Marketable securities
$144,937K
Cash and cash
equivalents
$150,698K
Other assets
$359K
Operating lease assets
$938K
Property and equipment,
net
$59K
Total current assets
$300,295K
Total assets
$301,651K
Total liabilities and
stockholders' equity
$301,651K
Total stockholders'
equity
$284,066K
Total liabilities
$17,585K
Accumulated deficit
-$494,117K
Accumulated other
comprehensive income (loss)
$109K
Additional paid-in capital
$778,065K
Operating lease
liabilities, non-current
$570K
Taxes payable,
non-current
$1,628K
Total current
liabilities
$15,387K
Common stock, 0.0001
par value,...
$9K
Current portion of
operating lease...
$459K
Accrued expenses and
other current...
$11,982K
Accounts payable
$2,946K
Buy me a coffee
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)